Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would […]
Healthcare spending bill draft includes many BIO requests Read More »
The Bayh-Dole Act was meant to encourage innovative research. However, some lawmakers are trying to change the intent of the law using the “march-in
‘Backdoor’ drug price controls will limit access to medicines, says expert Read More »
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political
Accelerated Approval is under political attack, experts say Read More »
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which
Senate Committee advances PBM transparency legislation Read More »
The Biotechnology Innovation Organization (BIO) is proud to celebrate Pride Month, which, in many places, is returning to in-person celebrations for the first time
Pride Month is back in person – here’s how biotech is celebrating Read More »
The World Trade Organization (WTO) agreed to waive COVID vaccine intellectual property protections—and many stakeholders are upset about it. Yes, the COVID vaccine IP
The COVID vaccine IP waiver is not a good idea – here’s why Read More »
We can support the development of biotechnology that reduces the environmental footprint of chemical manufacturing by correctly defining sustainable chemistry, states the Biotechnology Innovation
What is ‘sustainable chemistry’? BIO answers. Read More »
The World Trade Organization (WTO) agreed to “a waiver of certain requirements concerning compulsory licensing for COVID-19 vaccines.” However, the waiver of COVID vaccine
WTO agrees to COVID vaccine IP waiver – here’s what we know Read More »
Remarks from Paul Hastings, CEO of Nkarta Therapeutics and Chairman of the Biotechnology Innovation Organization (BIO), as prepared for delivery at the BIO International
